SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

PCVX

Vaxcyte, Inc.
NASDAQHealth Care

Latest close: 63.62 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 9, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Oct 5, 2026Reported sale · Form 4Jim Wassil, EVP, Chief Scientific Ofc, COO · $1.6MOpen the filing ↗
  3. Oct 5, 2026Reported sale · Form 4Elvia Cowan, SVP, Finance & CAO · $1.6MOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record73620 flagged findings
Reported transactions (Form 4)80since Jun 12, 2025 · and 18 other holdings
Corporate events (8-K)25since Dec 22, 2020

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-06share offering or dilution eventrecentOpen filing ↗
    “…the “2024 Shelf Registration Statement”). Pursuant to the 2024 Shelf Registration Statement, we may, from time to time, sell…”
    +1 more passage from the same document
    • “…value per share, of which 144,314,981 and 131,058,858 shares were issued and outstanding as of March 31, 2026 and December 31,…”
  • 2026-05-06capital return (buybacks/dividends)recentOpen filing ↗
    “…recorded within prepaid expenses and other current assets in the condensed consolidated balance sheets was immaterial as of…”
  • 2026-05-06regulatory investigationrecentOpen filing ↗
    “…or executive action, either in the United States or abroad. If we are slow or unable to adapt to changes in existing…”
  • 2026-02-24share offering or dilution eventrecentOpen filing ↗
    “…Partners acting as our sales agent. Our Common Stock is listed on the Nasdaq Global Select Market under the symbol “PCVX.” On…”
    +1 more passage from the same document
    • “…table), assuming sales of 8,297,378 shares of our Common Stock in this offering at an offering price of $60.26 per share, which…”
  • 2026-02-24capital return (buybacks/dividends)recentOpen filing ↗
    “…dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate; • our right, if…”
    +1 more passage from the same document
    • “…will accumulate; • our right, if any, to defer payment of dividends and the maximum length of any such deferral period; • the…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 736)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 9, 268-K ↗Current report · Took on a new financial obligation
  • Oct 8, 26424B5 ↗Securities offering
  • Oct 8, 26424B5 ↗Securities offering
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Oct 6, 26424B5 ↗Securities offering
  • Oct 6, 26424B5 ↗Securities offering
  • Notice of proposed sale · 2 Form 144 filingsshow all 2hide
  • Oct 5, 268-K ↗Current report · Communication to the market · Other events
  • Oct 2, 26Form 4 ↗Insider transaction
  • Oct 1, 26Form 144 ↗Notice of proposed sale
  • Sep 9, 26Form 4 ↗Insider transaction
  • Sep 9, 26Form 3 ↗Insider transaction
  • Sep 9, 26Form 144 ↗Notice of proposed sale
  • Insider transaction · 5 Form 4 filingsshow all 5hide
  • Sep 4, 26Form 144 ↗Notice of proposed sale
  • Sep 3, 268-K ↗Current report · A senior executive left or was appointed
  • Insider transaction · 3 Form 4 filingsshow all 3hide

736 filings on record, the oldest from Nov 8, 19.

Listing the 25 most recent filings of the 736 on record.

8-Ks, explained

Structure13Governance12
  • Oct 9, 26StructureTook on a new financial obligation+3 more in the same filing8-K 2.03 ↗
  • Governance4 senior executive changes2025 – 2026show all 4hide
    • Sep 3, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jul 15, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jun 23, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Dec 19, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Sep 30, 25StructureEntered a material agreement8-K 1.01 ↗
  • May 1, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Nov 21, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jul 2, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Nov 28, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Structure6 material agreements entered2022 – 2023show all 6hide
  • Dec 12, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Apr 18, 22StructureEntered a material agreement8-K 1.01 ↗
  • Governance3 senior executive changes2021show all 3hide
    • Oct 28, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Sep 20, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Mar 25, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jan 25, 21StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

1 older filings not shown

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • FMR LLC14.4%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
  • JANUS HENDERSON GROUP Ltd.12.1%Jul 31, 26SCHEDULE 13G/A ↗5 earlier filings
  • RA Capital Management, L.P.8.9%Mar 31, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • T. Rowe Price Investment Management, Inc.8.6%Dec 31, 25SCHEDULE 13G/A ↗1 earlier filing
  • Vanguard Capital Management5.0%Mar 31, 26SCHEDULE 13G ↗

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Oct 5, Cowan Elvia filed notice of intent to sell up to $1.6M. That is about 0.01% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $1.6M on Oct 5, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+9 more recent notices · 9 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Oct 5, 26Sell$1.6MJim WassilEVP, Chief Scientific Ofc, COO↗
  • Oct 5, 26Sell$1.6MElvia CowanSVP, Finance & CAO↗
  • Oct 1, 26Sell$122KJim WassilEVP, Chief Scientific Ofc, COO↗
  • Oct 1, 26Sell$5KJim WassilEVP, Chief Scientific Ofc, COO↗
  • Sep 9, 26Sell$79KJim WassilEVP, Chief Scientific Ofc, COO↗
  • Sep 4, 26Sell$84KJim WassilEVP, Chief Scientific Ofc, COO↗
  • Sep 1, 26Sell$94KJim WassilCHIEF OPERATING OFFICER↗
  • Sep 1, 26Sell$44KJim WassilCHIEF OPERATING OFFICER↗
  • Sep 1, 26Sell$56KJim WassilCHIEF OPERATING OFFICER↗
  • Sep 1, 26Sell$19KJim WassilCHIEF OPERATING OFFICER↗
  • Aug 5, 26Sell$935KHarpreet S. DhaliwalChief Technical Ops Officer↗
  • Aug 3, 26Sell$374KANDREW GUGGENHIMEPRESIDENT AND CFO↗

There are 4 more transactions in this stretch.

Stock compensation, tax and giftsshow the 24 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Oct 5, 26Compensation$96KJim WassilEVP, Chief Scientific Ofc, COO↗
  • Oct 5, 26Compensation$492KElvia CowanSVP, Finance & CAO↗
  • Oct 1, 26Compensation$12KJim WassilEVP, Chief Scientific Ofc, COO↗
  • Sep 8, 26Tax$432KANDREW GUGGENHIMEPRESIDENT AND CFO↗
  • Sep 8, 26Tax$1.0MGRANT PICKERINGCHIEF EXECUTIVE OFFICER↗
  • Sep 8, 26Tax$330KJim WassilEVP, Chief Scientific Ofc, COO↗
  • Sep 8, 26Tax$462KHarpreet S. DhaliwalChief Technical Ops Officer↗
  • Sep 8, 26Tax$80KElvia CowanSVP, Finance & CAO↗
  • Sep 4, 26Compensationamount n/aLuis JodarChief Medical Officer↗
  • Sep 2, 26Tax$88KANDREW GUGGENHIMEPRESIDENT AND CFO↗
  • Sep 2, 26Tax$211KGRANT PICKERINGCHIEF EXECUTIVE OFFICER↗
  • Sep 2, 26Tax$88KJim WassilCHIEF OPERATING OFFICER↗
  • Sep 2, 26Tax$41KHarpreet S. DhaliwalChief Technical Ops Officer↗
  • Sep 2, 26Tax$20KElvia CowanSVP, Finance & CAO↗
  • Sep 1, 26Compensation$12KJim WassilCHIEF OPERATING OFFICER↗
  • Aug 31, 26Tax$77KANDREW GUGGENHIMEPRESIDENT AND CFO↗
  • Aug 31, 26Tax$174KGRANT PICKERINGCHIEF EXECUTIVE OFFICER↗
  • Aug 31, 26Tax$77KJim WassilCHIEF OPERATING OFFICER↗
  • Aug 31, 26Tax$22KHarpreet S. DhaliwalChief Technical Ops Officer↗
  • Aug 31, 26Tax$15KElvia CowanSVP, Finance & CAO↗
  • Aug 5, 26Compensation$421KHarpreet S. DhaliwalChief Technical Ops Officer↗
  • Aug 3, 26Compensation$54KANDREW GUGGENHIMEPRESIDENT AND CFO↗
  • Aug 3, 26Compensation$12KJim WassilCHIEF OPERATING OFFICER↗
  • Jul 27, 26Compensation$33KGRANT PICKERINGCHIEF EXECUTIVE OFFICER↗

The full record holds 632 transactions and goes back to Dec 30, 22.

Its sector and its market

Vaxcyte, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Vaxcyte, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Vaxcyte, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
736 documents on file, from Nov 8, 2019 to Oct 9, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.